Biopsy-based clinical and histopathological characterization of cutaneous malignant melanoma
DOI:
https://doi.org/10.51481/amc.v56i2.834Keywords:
malignant melanoma, skin, biopsy, prognostic factorsAbstract
Background: The incidence of cutaneous melanoma has increased in recent decades, becoming a major cause of death worldwide. The objective was to characterize melanomas histologically and to determine the incidence based on the results of the biopsies of the Pathology Department of the San Rafael de Alajuela Hospital.
Methods: We conducted a review of each of the biopsies diagnosed as cutaneous melanoma with hematoxylin and eosin from January 2009 until December 2012 to determine their histological features. Simple frequencies were obtained for all variables and measures of central tendency and dispersion for the qualitative variables.
Results: A total of 28 cutaneous malignant melanomas were diagnosed, of which 16 occurred in male patients. The average age at presentation was 57.0 years and the most frequent location was the back and face. The superficial spreading melanoma is the predominant histologic type. In 15 cases, vertical invasion was found. In 21.1% of the cases the patients had Clark level III and Breslow thickness ranged from 0.20 to 8.00 mm. The predominant type was epithelioid cell morphology. Other histopathological variables such as mitotic count, vascular invasion, perineural invasion or ulceration were less frequently found.
Conclusions: Malignant melanoma occurs predominantly in male patients in their fifth decade of life; mainly in back and face. The most common histological type was superficial spreading melanoma.
Downloads
References
Duncan, M. The Classification of Cutaneous Melanoma. Hematol Oncol Clin N Am 2009; 23:501-513.
Mc Kee P. Pathology of the skin. 4th edition. Boston USA. 2012:1221-1266.
Ivan D, Prieto V. An Update on Reporting Histopathologic Prognostic Factors in Melanoma. Arch Pathol Lab Med. 2011;135:825-829.
Vicenti J, Mc Govern M, Artinc Jr, Christanbea C, Booth C, Clark J et al. The classification of Malignant Melanoma and its histologic reporting. Cancer December 1973;32:1446-1457.
Meltzer P. Genetic Diversity in Melanoma. N Engl J Med 2005;353;20:2104-2107.
Niezabitowski A, Czajecki K, Rys J, Kruczak A, Gruchala A, Wasilewska A et al. Prognostic Evaluation of Cutaneous Malignant Melanoma: A Clinicopathologic and Immunohistochemical Study. J Surg Oncology 1999;70:150-160.
Weyers W, Euler M. .Diaz-Cascajo C, Bonczkowitz M. Classification of Cutaneous Malignant Melanoma. A Reassessment of Histopathologic Criteria for the Distinction of Different Types. Cancer 1999;86:288-299.
Keefe M, Mackie R. The relationship between risk of death from clinical stage I cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Br. J. Cancer 1991;64:598602.
C. Schmoeckel, .O Braun-Falco. Prognostic Index in Malignant Melanoma. Arch Dermatol 1978;114:871-873.
Wallace H, Clark, Jr, Lynn F, Evelina A, Bernardino,and Martin C. The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin. Cancer research 1969;29:705726.
Azzola M, Shaw, Thompson J, Soong S, Scolyer R, Watson G et al. Tumor Mitotic Rate Is a More Powerful Prognostic Indicator than Ulceration in Patients with Primary Cutaneous Melanoma. Cancer 2003:97:1488-1498.
Balch C, Buzaid A, Soong S, Atkins M, Cascinelli N, Coit D, et al. New TNM Melanoma Staging System: Linking Biology and Natural History to Clinical Outcomes. Surg Onc 2003;21:43-52.
Balch C, Wilkerson J, Murad T, Soongs S,Ingalls A, Maddox W. The Prognostic Significance of Ulceration of Cutaneous Melanoma. Cancer 1980;45:3012-3017.
Hacene K, Le Doussal V, Brunet M, et al. Prognostic Index for Clinical Stage I Cutaneous Malignant Melanoma. Cancer Res 1983;43:2991-2996.
Sarpa G, Reinke K, Shaikh L, Leong S, Miller J, Sagebiel R, and Kashani-Sabet M. Prognostic Significance of Extent of Ulceration in Primary Cutaneous Melanoma. Am J Surg Pathol 2006;30:1396-1400.
Downloads
Published
Versions
- 2014-04-03 (2)
- 2014-04-03 (1)
Issue
Section
License
Copyright (c) 2014 Acta Médica Costarricense

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)



